US industry coalition tells HCFA (US Health Care Financing Administration) to ignore cost-effectiveness
This article was originally published in Clinica
The US Health Care Financing Administration (HCFA),the agency that regulates Medicare, the federal health plan for the elderly and disabled, was told to exclude cost-effectiveness considerations from its coverage process by a coalition of medical device organisations last week.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.